Evariste
PrivateCompany Overview
Evariste operates in AI, Data & Cloud Infrastructure and is based in London. It was founded in 2017.
Evariste is a biotechnology company that uses mathematics and artificial intelligence to develop small molecule therapeutics for oncology.
Sector
AI, Data & Cloud Infrastructure
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evariste Comparables
Compare Evariste with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aqemia | 87% | |
| Iktos | 85% | |
| Genesis Therapeutics | 84% |
For institutional investors. Book with your work email.
Evariste Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors grew 62% MoM, reaching 1.8K.
- Dec 9, 2025
Monthly visitors grew 168% MoM.
For institutional investors. Book with your work email.
Evariste Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evariste's valuation, stock price, and market status.
Is Evariste a public or private company?
Evariste is a private company.
What is the current stock price of Evariste?
Evariste is a private company, so its shares have no public market price. Caplight tracks Evariste's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evariste worth (valuation)?
Valuation information for Evariste is not publicly available.
Can I buy Evariste stock?
Evariste shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evariste's last funding round?
Funding round information for Evariste is not publicly available.
Who are the main investors in Evariste?
Investor information for Evariste is not publicly disclosed.
Will Evariste IPO soon?
No public IPO plans have been announced for Evariste.
How can I track Evariste secondary market activity?
Caplight tracks bids, offers, and trades in Evariste's shares on secondary markets.